Posts Tagged ‘digoxin’

May 4th, 2015

Increased Mortality Risk Found With Digoxin

For more than 200 years physicians have been trying to figure out how and when to use digoxin. Although it has a narrow therapeutic window and potentially dangerous interactions with other drugs, it is endorsed by current guidelines and widely given to patients with heart failure (HF) and atrial fibrillation (AF). However, there have been no […]

April 9th, 2015

Digoxin Use in Afib: Revisiting Data from ROCKET AF

Manesh R. Patel discusses his research group’s retrospective analysis of data on digoxin use among patients with atrial fibrillation in the ROCKET AF trial.

August 11th, 2014

What’s the Next Phase for Digoxin in Patients with Atrial Fibrillation?

Mintu P. Turakhia discusses his observational study of digoxin use and mortality risk in patients with atrial fibrillation, using data from the TREAT-AF study.

August 11th, 2014

Study Offers Little Support for an Old Drug

Digoxin is one of the oldest drugs in the cardiovascular arsenal, derived from the foxglove plant and first described in the 18th century by William Withering. It is frequently used in patients with heart failure (HF) and with atrial fibrillation (AF). The few trials supporting its use were performed in HF patients before newer treatments […]

October 17th, 2013

Questioning Digoxin Use for Patients with Systolic HF

James Freeman discusses his research group’s evaluation of the contemporary effectiveness and safety of digoxin therapy among adults with newly diagnosed systolic heart failure.

September 24th, 2013

Study Raises Questions About Digoxin Use Today

Digoxin is one of the oldest medicines in the cardiovascular arsenal. When William Withering identified it as the active ingredient in the foxglove plant more than 200 years ago, he was only codifying a longstanding folk remedy for heart failure, or “dropsy” as it was known then. Digoxin fully entered the modern era with the publication […]

March 21st, 2013

DIGging In: Three Reasons Why the Recent Digoxin Study Is Not Relevant to Readmission

The evidence is just not compelling that this this drug would reduce hospital readmissions